Shanghai Junshi Biosciences Co Ltd (688180)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 30.31 |
|---|---|
| 52-week range | 28.10 – 46.55 |
| Return, 1 month / 3 months | −4.3% / −19.6% |
| Return, 1 year / 3 years | −29.1% / −20.0% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 46.8% |
| Worst drawdown (1 year) | -35.8% |
| Average daily value traded | 576.88M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shanghai Junshi Biosciences is a biopharmaceutical company based in Shanghai that discovers, develops and commercialises antibody-based medicines. Its work centres on immunotherapy for cancer, with a portfolio that includes a PD-one inhibitor approved for several tumour types, along with antibody candidates for infectious and autoimmune disease. The company serves patients and healthcare providers through hospitals and medical institutions in China and other markets, and it also pursues partnerships with other drug developers to advance its pipeline.
Shanghai Junshi Biosciences Co Ltd trades under the code 688180 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shanghai Junshi Biosciences Co Ltd (688180) trades on the Shanghai Stock Exchange in China. It last closed at CNY 30.31 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 919 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.1% and over the last three months it fell 19.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -14.6% | ||
| From 52-week high | -32.7% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.6% | ||
| 6-month return | -20.4% | ||
| 12-month return, skipping the last month | -26.0% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.8% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 576.88M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −7.0% |
|---|---|
| 1 month | −4.3% |
| 3 months | −19.6% |
| 6 months | −20.4% |
| 1 year | −29.1% |
| 3 years | −20.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 34.78 / 35.49 |
|---|---|
| Golden / death cross (60 days) | Death, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.42 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.